BIIB Biogen

Biogen Inc. Stock Rises Friday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB rose 3.28% to $210.63 Friday, on what proved to be an all-around great tra

07-02 04:41

Biogen Inc. Stock Outperforms Market Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB dropped 0.63% to $203.94 Thursday, on what proved to be an all-around roug

07-01 04:40

Acumen Pharmaceuticals initiated at buy at H.C. Wainwright on Alzheimer's candidate

H.C. Wainwright has initiated Acumen Pharmaceuticals (NASDAQ:ABOS) with a buy rating saying the biopharma's early-stage Alzheimer's candidate, ACU193, has promise. The firm has a $15 price target (~20

07-01 03:52

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors. What To Know: J

07-01 00:10

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB advanced 1.34% to $205.23 Wednesday, on what proved to be an all-around mi

06-30 04:41

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB shed 5.18% to $202.51 Tuesday, on what proved to be an all-around rough tr

06-29 04:41

Peering Into Biogen's Recent Short Interest

Biogen's (NASDAQ:BIIB) short percent of float has risen 9.27% since its last report. The company recently reported that it has 2.41 million shares sold short, which is 1.65% of all regular shares that

06-28 22:25

Biogen Inc. Stock Rises Monday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB inched 0.77% higher to $213.57 Monday, on what proved to be an all-around

06-28 04:41

Here's How Much $100 Invested In Biogen 15 Years Ago Would Be Worth Today

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.63% on an annualized basis producing an average annual return of 10.11%. Currently, Biogen has a market capitalization of $

06-28 00:15

Biogen Inc. Stock Rises Friday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Biogen Inc. BIIB inched 0.26% higher to $211.93 Friday, on what proved to be an all-around

06-25 04:40